AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CRANEWARE PLC

Share Issue/Capital Change Apr 15, 2019

7581_rns_2019-04-15_735aacdd-638d-438d-a750-38ab6afa67e5.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0853W

Craneware plc

15 April 2019

Schedule 6, Block Admission Period to 15 April 2019

This block admission announcement, as required by the AIM Rules, is made every six months and relates to the number of shares that have been issued and allotted during this six month period under the Company's block listing for approved share option plans.

Name of the company Craneware plc
Names of the schemes Approved Share Option Plan 2007
Period of return: 16/10/2018 to 15/4/2019
Balance of unallotted securities under scheme(s) from previous return: Approved Share Option Plan 2007:

97,637 ordinary shares of 1p each
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): None
Less: Number of securities issued/allotted under scheme(s) during period: None
Equals: Balance under scheme(s) not yet issued/allotted at end of period: Approved Share Option Plan 2007:

97,637 ordinary shares of 1p each
Number and class of securities originally admitted at the date of admission: 24,929,950 ordinary shares of 1p each on 13 September 2007
Contact name and telephone number: Craig Preston +44 (0) 131 550 3100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BLRUUVURKUASAAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.